Measurement of fractionated plasma metanephrines for exclusion of pheochromocytoma: Can specificity be improved by adjustment for age?
<p>Abstract</p> <p>Background</p> <p>Biochemical testing for pheochromocytoma by measurement of fractionated plasma metanephrines is limited by false positive rates of up to 18% in people without known genetic predisposition to the disease. The plasma normetanephrine fr...
Main Authors: | Gafni Amiram, Thabane Lehana, Sawka Anna M, Levine Mitchell, Young William F |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2005-02-01
|
Series: | BMC Endocrine Disorders |
Online Access: | http://www.biomedcentral.com/1472-6823/5/1 |
Similar Items
-
A systematic review of the literature examining the diagnostic efficacy of measurement of fractionated plasma free metanephrines in the biochemical diagnosis of pheochromocytoma
by: Thabane Lehana, et al.
Published: (2004-06-01) -
Plasma metanephrines: a novel and cost-effective test for pheochromocytoma
by: G. Eisenhofer, et al.
Published: (2000-10-01) -
Plasma free metanephrine, normetanephrine, and 3-methoxytyramine for the diagnosis of pheochromocytoma/paraganglioma
by: Poonam Gupta, et al.
Published: (2015-01-01) -
Urinary Free Metanephrines for Diagnosis of Pheochromocytoma and Paraganglioma
by: Jiyeon Ahn, et al.
Published: (2021-06-01) -
Measurements of Plasma-Free Metanephrines by Immunoassay Versus Urinary Metanephrines and Catecholamines by Liquid Chromatography with Amperometric Detection for the Diagnosis of Pheochromocytoma/Paraganglioma
by: Wolfgang Raber, et al.
Published: (2020-09-01)